Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Stevenson

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
American Heart Journal|July 1, 1992
Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failureW G Stevenson, H R Middlekauff, L W Stevenson, et al.
Circulation|January 1, 1990
Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failureL W Stevenson, K Sietsema, J H Tillisch, et al.
Circulation|November 1, 1995
Target heart failure populations for newer therapiesL W Stevenson, G Couper, B Natterson, et al.
The American Journal of Cardiology|September 2, 1998
Recipient-to-donor atrioatrial conduction after orthotopic heart transplantation: surface electrocardiographic features and estimated prevalenceD C Lefroy, J C Fang, L W Stevenson, et al.
Journal of the American College of Cardiology|February 1, 1991
Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomographyF V Mody, R C Brunken, L W Stevenson, et al.
Journal of the American College of Cardiology|September 19, 1998
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular DysfunctionD L Dries, D V Exner, B J Gersh, et al.
The American Journal of Cardiology|July 1, 1993
Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyL A Saxon, W G Stevenson, H R Middlekauff, et al.
Journal of the American College of Cardiology|April 1, 1993
Is intravenous glucocorticoid therapy better than an oral regimen for asymptomatic cardiac rejection? A randomized trialJ A Kobashigawa, L W Stevenson, J D Moriguchi, et al.
Circulation|November 9, 2000
Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart AssociationK L Grady, K Dracup, G Kennedy, et al.
Circulation|November 11, 1991
Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantationH W Louie, H Laks, E Milgalter, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
American Heart Journal|July 1, 1992
Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failureW G Stevenson, H R Middlekauff, L W Stevenson, et al.
Circulation|January 1, 1990
Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failureL W Stevenson, K Sietsema, J H Tillisch, et al.
Circulation|November 1, 1995
Target heart failure populations for newer therapiesL W Stevenson, G Couper, B Natterson, et al.
The American Journal of Cardiology|September 2, 1998
Recipient-to-donor atrioatrial conduction after orthotopic heart transplantation: surface electrocardiographic features and estimated prevalenceD C Lefroy, J C Fang, L W Stevenson, et al.
Journal of the American College of Cardiology|February 1, 1991
Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomographyF V Mody, R C Brunken, L W Stevenson, et al.
Journal of the American College of Cardiology|September 19, 1998
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular DysfunctionD L Dries, D V Exner, B J Gersh, et al.
The American Journal of Cardiology|July 1, 1993
Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyL A Saxon, W G Stevenson, H R Middlekauff, et al.
Journal of the American College of Cardiology|April 1, 1993
Is intravenous glucocorticoid therapy better than an oral regimen for asymptomatic cardiac rejection? A randomized trialJ A Kobashigawa, L W Stevenson, J D Moriguchi, et al.
Circulation|November 9, 2000
Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart AssociationK L Grady, K Dracup, G Kennedy, et al.
Circulation|November 11, 1991
Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantationH W Louie, H Laks, E Milgalter, et al.
Pageof 14